Do not administer to young foals
less than 4 months of age.
EQUEST Oral Gel is formulated
specifically for use in horses only. Dogs or cats may be
adversely affected by the concentration of moxidectin in this
product if they are allowed to ingest spilled paste or have
access to used syringes.
Do not use the same syringe to
treat more than one animal unless horses are running together or
in direct contact with each other on the same premises.
Do not smoke, drink or eat while
handling the product.
The use of protective gloves is
recommended.
Wash hands or any exposed area
after use.
Avoid direct contact with skin and
eyes.
In the event of eye contact, flush
the eye with copious amounts of clean water and seek medical
advice.
For animal treatment only.
Keep out of the reach of children.
Read entire package insert before
use.
Environmental safety
EQUEST Oral Gel is toxic to fish
and aquatic organisms. Do not contaminate ponds, waterways or
ditches with product or used syringes. Dispose of any unused
product and empty syringes in accordance with guidance from your
local waste regulation authority.
Uses
Moxidectin is a second generation macrocyclic
lactone of the milbemycin family.
For the treatment and control of adult and
larval stages of important internal parasites
including encysted inhibited EL3 and developing
intramucosal L4 larval stages of small redworms,
arterial stages of large redworms and bots in
horses and ponies with a single dose.
EQUEST Oral Gel, at the recommended dosage level
of 400 mcg moxidectin per kg bodyweight,
provides effective control of moxidectin
sensitive strains of the following parasites of
horses and ponies:
Large strongyles:
Strongylus vulgaris (adults and arterial
stages)
Strongylus edentatus (adults and visceral
stages)
Triodontophorus brevicauda (adults)
Triodontophorus serratus (adults)
Triodontophorus tenuicollis (adults)
Small strongyles (adults
and intraluminal larval stages):
Cyathostomum spp.
Cylicocyclus spp.
Cylicostephanus spp.
Cylicodontophorus spp.
Gyalocephalus spp.
EQUEST Oral Gel is effective against
(developing) intramucosal L4 stages of small
strongyles. At eight weeks after treatment early
(hypobiotic) EL3 stages of small strongyles are
eliminated.
EQUEST Oral Gel is effective against
benzimidazole resistant strains of cyathostomes.
Ascarids:
Parascaris equorum (adult and larval
stages)
Other species:
Oxyuris equi (adult and larval stages)
Habronema muscae (adults)
Gasterophilus intestinalis (L2, L3)
Gasterophilus nasalis L2, L3)
Strongyloides westeri (adults)
Trichostrongylus axei
EQUEST Oral Gel has a persistent effect in
preventing infection by small strongyles for 2
weeks after dosing and suppresses the presence
of small strongyle eggs in the dung for 90 days.
